Show results for
Refine by
Blood Typing Services
5 services found
Manufactured by:Jarvik Heart, Inc. based inNew York, NEW YORK (USA)
The Jarvik 2000® is designed to provide reliable support to the ailing heart for a decade or longer. Accelerated tests of the pump’s bearings show that there is so little wear that the bearings will last decades, so many more years of real-time testing are required to know whether or not the pump will achieve or exceed this challenging design objective. Presently, our longest-sustained ...
Manufactured by:Creative Bioarray based inShirley, NEW YORK (USA)
CD34+ cells have been shown to possess colony-forming potential in short-term assays, maintain long-term colony-forming potential in in vitro culture, and allow the expression and differentiation of blood cells from different hematopoietic lineages in in vivo models. The CD34+ progenitor cells contain two main cell subpopulations, hematopoietic and endothelial progenitor cells. ...
by:ICON plc based inDublin, IRELAND
ICON works with clients to meet your trial needs in blood banking. We can help you with clinical, compliance and FDA CDRH, CBER and international regulatory requirements for blood banking / blood collection related products and ...
Manufactured by:InvivoSciences, Inc. (IVS) based inMadison, WISCONSIN (USA)
Human engineered tissue (EHT)-based high content analysis can be applied to drug discovery projects at their compound screening and lead optimization stage. Mass-produced human engineered tissues will recapitulate physiological functions of native tissues in micro tissues growing in 96-well plates or 384-well plates (coming soon). Patient-derived cells can also be used to fabricate engineered ...
Manufactured by:Pluristem Therapeutics Inc. based inHaifa, ISRAEL
Bone marrow deficiency refers to a condition in which the hematopoietic stem cells in the bone marrow fail to produce enough, or produce abnormal, red blood cells, white blood cells and platelets. Hematopoietic cell transplantation (HCT), the transplantation of multipotent hematopoietic cells, is a standard treatment in various malignant and non-malignant conditions. Transplant patients are ...